Results 301 to 310 of about 574,105 (363)

Dual‐Functional Polyphosphoesters for Gene Delivery: Synergistic Effects of Guanidinium and Hydrophobic Side Chains in Degradable Polymers

Advanced Healthcare Materials, EarlyView.
This study presents guanidinium‐ and indole‐functionalized polyphosphoesters as degradable, non‐viral gene delivery vectors. Through precise tuning of charge density and hydrophobicity, these polymers form stable polyplexes with low toxicity. Remarkably, minor structural changes yield up to 200‐fold differences in transfection efficiency, highlighting ...
Markus Kötzsche, Andreas Dzierza, Jan Egger, Timo Rheinberger, Christin Weilandt, Frederik R. Wurm, Ivo Nischang, Dagmar Fischer, Kalina Peneva   +8 more
wiley   +1 more source

Pharmaceutical Industry Payments to Professional Medical Societies in Japan. [PDF]

J Gen Intern Med
Murayama A, Higuchi K, Senoo Y.
europepmc   +1 more source

The Application of Membrane Separation Technology in the Pharmaceutical Industry. [PDF]

Membranes (Basel)
Ma R, Li J, Zeng P, Duan L, Dong J, Ma Y, Yang L.   +6 more
europepmc   +1 more source

Could I become a physician in the pharmaceutical industry?: practical insights from a 12-year veteran in pharma. [PDF]

Ewha Med J
Lee Y.
europepmc   +1 more source

Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review. [PDF]

J Mark Access Health Policy
Fatoye C, Yeowell G, Miller E, Odeyemi I, Mbada C.   +4 more
europepmc   +1 more source

Research on the impact of technology mergers and acquisitions on corporate performance: an empirical analysis based on China's pharmaceutical industry. [PDF]

Front Public Health
Yang J, Li J, Wang S, Chen Y.
europepmc   +1 more source

Human resources and sustaining competitive advantage in the North East pharmaceutical industry

, 1999
PS Benneworth, David Charles
openalex  

PHARMACEUTICAL INDUSTRY IN PAKISTAN: UNETHICAL PHARMACEUTICAL MARKETING PRACTICES

Market Forces, 2008
doaj